The US Bankruptcy Court gave an order approving the sale of the certain assets of Genocea Biosciences, Inc. on August 17, 2022. The debtor has been authorized to sell its certain assets to Commercialization of Regenerative Medicine, for a purchase price of $0.63 million in cash. The debtor's assets include purchased equipment.

The buyer is represented by Sandra E. Mayerson as its legal counsel and the seller is represented by Harold Murphy of Murphy & King PC as its legal advisor.